gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
A method for producing a recombinant protein.
|
gptkbp:applicationNumber
|
10/780,123
|
gptkbp:applicationPublicationNumber
|
gptkb:US_2004/0123456_A1
|
gptkbp:applicationType
|
non-provisional
|
gptkbp:assignee
|
gptkb:ABC_Corporation
|
gptkbp:assigneeCountry
|
gptkb:USA
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:class
|
C12N_15/00
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:description
|
This patent describes a novel method for gene expression.
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
2024-02-06
|
gptkbp:fieldOfInvention
|
biotechnology
|
gptkbp:fieldOfUse
|
pharmaceuticals
|
gptkbp:filedIn
|
gptkb:United_States
|
gptkbp:filingDate
|
2004-02-06
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,148 C11
|
gptkbp:internationalClassification
|
C12N_15/00
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:inventorCountry
|
gptkb:USA
|
gptkbp:issueDate
|
2004-09-14
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
gptkbp:legalStatus
|
granted
|
gptkbp:maintenanceFee
|
paid
|
gptkbp:patentAbstract
|
active
high
available
significant
recombinant DNA technology
2004-02-06
|
gptkbp:patentAssignee
|
gptkb:ABC_Corporation
|
gptkbp:patentCitation
|
ongoing
exclusive
cited by 15 other patents.
|
gptkbp:patentExpiration
|
2024-02-06
|
gptkbp:patentFamily
|
US_6,789,148_C11,_US_6,789,149_C12
|
gptkbp:patentInventor
|
gptkb:John_Doe
|
gptkbp:patentLitigation
|
none
|
gptkbp:patentNumber
|
gptkb:US_6,789,148_B1
6,789,148
|
gptkbp:patentOffice
|
gptkb:USPTO
|
gptkbp:patentOwner
|
gptkb:ABC_Corporation
|
gptkbp:patentType
|
utility
2004-09-14
Utility patent for a process.
10/780,123
|
gptkbp:priorityDate
|
2003-02-06
|
gptkbp:relatedPatent
|
US_6,789,149_C12
|
gptkbp:relatedTo
|
US_6,789,147_C10
|
gptkbp:researchField
|
molecular biology
|
gptkbp:status
|
active
|
gptkbp:subclass
|
C12N_15/10
|
gptkbp:technicalField
|
genetic engineering
|